Heart changes after carbetocin for planned c-section
Treatments studied
Part of Heart & circulation clinical trials.
This trial studies how a medicine called carbetocin affects the heart during planned cesarean sections. It may help doctors understand how to use this drug safely for mothers without heart conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a planned (elective) cesarean section.
- This can be your first or a repeat c-section.
- You do not have any heart or blood vessel problems, including pre-eclampsia.
- Your body mass index (BMI) is 50 or less.
- You do not have a bleeding disorder or allergy to carbetocin.
- You are 18 years old or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well different doses of a contraction medicine work after an initial dose in women having a planned C-section. It may help find the best way to prevent bleeding after birth.
This study tests if giving carbetocin with calcium helps the uterus contract better after a planned c-section. It's for women at 37+ weeks without high risk for poor uterine tone.
This study compares two medicines—carbetocin and oxytocin—given during a planned cesarean to help prevent heavy bleeding after delivery. It is for women who have certain risk factors for uterine atony (when the uterus does not tighten up after birth).
This trial tests if adding calcium changes how well a drug called carbetocin works to make the uterus contract after a planned C-section. It may help doctors prevent heavy bleeding after delivery.
This trial studies how three medications (ephedrine, phenylepinephrine, and norepinephrine) affect the contraction strength of uterine muscle tissue from pregnant people with type 2 or gestational diabetes during planned C-sections. It aims to understand if these drugs act differently in people with diabetes, which could help tailor safer treatments for low blood pressure during surgery.
This trial compares two medication approaches to prevent excessive bleeding during planned cesarean delivery under spinal anesthesia. Researchers want to see if one medication (carbetocin) works as well as carbetocin combined with a second medication (oxytocin).
Hear when a new Cesarian Section trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.